EX-4.19





 Exhibit 4.19 
  

 
  

 
 PRINCIPAL STOCKHOLDERS AGREEMENT 

BY AND AMONG 

ATOTECH LIMITED 

AND 
 THE
CARLYLE STOCKHOLDERS 
 FEBRUARY 3, 2021 

 
  
  

 












 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
		
	 SECTION I. DEFINITIONS
	  	 	1	 
	 1.1
	  	 Drafting Conventions; No Construction Against Drafter
	  	 	1	 
	 1.2
	  	 Defined Terms
	  	 	2	 
		
	 SECTION II. REPRESENTATIONS AND WARRANTIES
	  	 	4	 
	 2.1
	  	 Representations and Warranties of the Initial Carlyle Stockholder
	  	 	4	 
	 2.2
	  	 [Reserved.]
	  	 	4	 
	 2.3
	  	 Representations and Warranties of the Company
	  	 	4	 
		
	 SECTION III. BOARD MATTERS
	  	 	5	 
	 3.1
	  	 Board of Directors
	  	 	5	 
	 3.2
	  	 Committees of the Board of Directors
	  	 	6	 
	 3.3
	  	 Additional Management Provisions
	  	 	7	 
	 3.4
	  	 Company
	  	 	7	 
		
	 SECTION IV. REGISTRATION RIGHTS
	  	 	7	 
	 4.1
	  	 Demand and Piggyback Rights.
	  	 	7	 
	 4.2
	  	 Notices, Cutbacks and Other Matters.
	  	 	9	 
	 4.3
	  	 Facilitating Registrations and Offerings.
	  	 	11	 
	 4.4
	  	 Indemnification.
	  	 	16	 
	 4.5
	  	 Rule 144
	  	 	19	 
		
	 SECTION V. MISCELLANEOUS PROVISIONS
	  	 	19	 
	 5.1
	  	 Information and Access Rights
	  	 	19	 
	 5.2
	  	 Confidentiality
	  	 	21	 
	 5.3
	  	 Reliance
	  	 	21	 
	 5.4
	  	 Access to Agreement; Amendment and Waiver; Actions of the Board
	  	 	22	 
	 5.5
	  	 Notices
	  	 	22	 
	 5.6
	  	 Counterparts
	  	 	23	 
	 5.7
	  	 Remedies; Severability
	  	 	23	 
	 5.8
	  	 Entire Agreement
	  	 	23	 
	 5.9
	  	 Termination
	  	 	23	 
	 5.10
	  	 Governing Law
	  	 	23	 
	 5.11
	  	 Successors and Assigns; Beneficiaries
	  	 	23	 
	 5.12
	  	 Consent to Jurisdiction; Specific Performance; Waiver of Jury Trial
	  	 	24	 
	 5.13
	  	 Further Assurances; Company Logo
	  	 	24	 
	 5.14
	  	 Regulatory Matters
	  	 	24	 
	 5.15
	  	 Inconsistent Agreements
	  	 	25	 
	 5.16
	  	 In-Kind Distributions
	  	 	25	 
	 5.17
	  	 Recapitalization Transactions
	  	 	25	 
	 5.18
	  	 Conflict with Jersey Law
	  	 	25	 

 EXHIBIT 
 Exhibit
A: Form of Joinder Agreement 

  
 i 













 PRINCIPAL STOCKHOLDERS AGREEMENT 

This Principal Stockholders Agreement (this “Agreement”) is made as of February 3, 2021 by and among Atotech Limited, a
company incorporated under the laws of Jersey (the “Company”), Carlyle Partners VI Cayman Holdings, L.P. (“CP-VI”), CEP IV Participations, S.à r.l. SICAR
(“CEP IV”), Gamma Holding Company Limited (“Gamma Holding” and, together with CP-VI and CEP IV, the “Initial Carlyle Stockholders”), and any other stockholder
who from time to time becomes party to this Agreement by execution of a joinder agreement substantially in the form of Exhibit A (a “Joinder Agreement”). 

RECITALS 
 A. Whereas, the
Initial Carlyle Stockholders are party to that certain Share for Share Exchange Agreement, dated as of January 17, 2020 (the “Exchange Agreement”), pursuant to which the Initial Carlyle Stockholders contributed shares of
Atotech UK Topco to the Company, in exchange for shares of the Company. 
 B. Whereas, the Company is proposing to consummate an initial
public offering of its share capital (the “Initial Public Offering”). 
 C. Whereas, the Initial Carlyle Stockholders and
the Company desire to enter into this Agreement effective upon the effective date of the registration statement relating to the Initial Public Offering (the “Effective Date”). 

D. Whereas, the board of directors of the Company (the “Board of Directors”) has approved this Agreement. 

E. Whereas, the parties hereto desire to agree upon the respective rights and obligations after the Effective Date with respect to the
securities of the Company now or hereafter issued and outstanding and held by the parties to this Agreement and certain matters with respect to their investment in the Company. 

AGREEMENT 
 Now therefore,
in consideration of the foregoing, and the mutual agreements and covenants contained herein, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 

SECTION I. DEFINITIONS 
 1.1 Drafting
Conventions; No Construction Against Drafter. 
 (a) The headings in this Agreement are provided for convenience and do not affect its
meaning. The words “include,” “includes” and “including” are to be read as if they were followed by the phrase “without limitation.” Unless specified otherwise, any reference to an agreement means that
agreement as amended or supplemented, subject to any restrictions on amendment contained in such agreement. Unless specified otherwise, any reference to a statute or regulation means that statute or regulation as amended or supplemented from time to
time and any corresponding provisions of successor statutes or regulations. If any date specified in this Agreement as a date for taking action falls on a day that is not a business day, then that action may be taken on the next business day. Unless
specified otherwise, the words “party” and “parties” refer only to a party named in this Agreement or one who joins this Agreement as a party pursuant to the terms hereof. 

  
 1 













 (b) The language used in this Agreement shall be deemed to be the language chosen by the
parties to express their mutual intent. If an ambiguity or question of intent or interpretation arises, this Agreement is to be construed as if drafted jointly by the parties and there is to be no presumption or burden of proof or rule of strict
construction favoring or disfavoring any party because of the authorship of any provision of this Agreement. 
 1.2 Defined Terms.
The following capitalized terms, as used in this Agreement, shall have the meanings set forth below. 
 “Adverse
Disclosure” means public disclosure of material non-public information that, in the good faith judgment of the Company, upon advice of counsel and as authorized by a resolution of the disinterested
members of the Board of Directors of the Company, would require premature disclosure of any material financing, material corporate reorganization or other material transaction, obligation, fact or event involving the Company, as the case may be.

 “Affiliate” means with respect to any specified Person, any other Person that, directly or indirectly, controls, is
controlled by or is under common control with the specified Person, including any general partner, partner, officer, director, managing member or member of the specified Person and, if the specified Person is a private equity fund, any investment
fund now or hereafter managed by, or that is controlled by or is under common control with, one or more general partners or managing members of, or shares the same management company with, the specified Person or any investment fund, managed account
vehicle, collective investment scheme or comparable investment vehicle (“Fund”) now or hereafter existing that shares the same management company or registered investment advisor with such Person or any Fund now or hereafter
existing that is controlled by, under common control with, managed or advised by the same management company or registered investment advisor that controls, is under common control with, manages or advises the Fund that controls such Person. For the
purposes of this definition, “control” (including, with its correlative meanings, the terms “controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or
indirectly, of the power to direct, or cause the direction of the management and policies of such Person, whether through the ownership of securities, by contract or otherwise. 

“Articles” means the Company’s Articles of Association in effect as of the Effective Date, as amended from time to time.

 “Carlyle Stockholders” means (i) the Initial Carlyle Stockholders and (ii) any Permitted Transferee or
Affiliate of any Initial Carlyle Stockholder (x) that is issued Common Stock or becomes the beneficial owner of any Common Stock or is Transferred any Common Stock by any other Person and (y) that becomes a party hereto by executing a
Joinder Agreement. 
 “Carlyle Majority Interest” means, at any given time, the Carlyle Stockholders holding a majority of
the outstanding Shares held at that specified time by all Carlyle Stockholders. 
 “Common Stock” means the common shares,
par value $0.10 per share, of the Company. 
 “Company” shall have the meaning set forth in the preamble and shall include
any successor thereto. 
 “Company’s Secretary” means any company secretary and/or any assistant company secretary in
Jersey or elsewhere appointed from time to time. 
 “Director” means a member of the Board of Directors. 

  
 2 













 “Exchange Act” means the Securities Exchange Act of 1934 and the rules and
regulations thereunder. 
 “IFRS” means International Financial Reporting Standards as adopted by the European Union. 

“Initial Capital Interest” means the aggregate sums which remain invested by a Stockholder in shares and yield free
convertible preferred equity certificates of the Company immediately following the IPO. 
 “IPO” means the underwritten
registered public offering of the Company’s Common Stock pursuant to which the Common Stock is being listed on the New York Stock Exchange. 

“Jersey Companies Law” means the Companies (Jersey) Law 1991, as amended. 

“Jersey Consents” means the consents to the circulation of a prospectus granted by the JFSC to the Company in accordance with
the Companies (General Provisions) (Jersey) Order 2002, as amended and the Control of Borrowing (Jersey) Order 1958. 

“JFSC” means the Jersey Financial Services Commission, including the Jersey Companies Registry. 

“Memorandum of Association” means the Company’s Memorandum of Association in effect as of the date hereof, as amended
from time to time. 
 “Necessary Action” means, with respect to a specified result, all actions necessary or desirable to
cause such result, including (i) attending meetings in person or by proxy for purposes of obtaining a quorum, (ii) voting or providing a written consent or proxy with respect to Shares, (iii) causing the adoption of resolutions and
amendments to the organizational documents of the Company, (iv) executing agreements and instruments, (v) making, or causing to be made, with governmental, administrative or regulatory authorities, all filings, registrations or similar
actions that are required to achieve such result and (vi) ensuring that applicable provisions are included in any proxy statement prepared by management of the Company in connection with the solicitation of proxies for any meeting of
shareholders of the Company. 
 “Permitted Transferee” means, with respect to any Carlyle Stockholder, (i) any
Affiliate of such Carlyle Stockholder, (ii) any director, officer or employee of any Affiliate of such Carlyle Stockholder, (iii) any direct or indirect member or general or limited partner of such Carlyle Stockholder that is the
transferee of Shares pursuant to a pro rata distribution of Shares by such Carlyle Stockholder to its partners or members, as applicable (or any subsequent transfer of such Shares by the transferee to another Permitted Transferee) or (iv) any
other Transferee designated as a Permitted Transferee by the Carlyle Majority Interest. 
 “Person” means an individual,
corporation, partnership, limited liability company, joint venture, association, trust, unincorporated organization, government (or agency or political subdivision thereof) or any other entity or group (as defined in Section 13(d) of the
Exchange Act). 
 “Public Offering” means a public offering and sale of Common Stock for cash pursuant to an effective
registration statement under the Securities Act. 
 “SEC” means the Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933 and the rules and regulations thereunder. 

  
 3 













 “Shares” means, at any time, (i) Common Stock and (ii) any other
equity securities now or hereafter issued by the Company, together with any options thereon and any other shares or other equity securities issued or issuable with respect thereto (whether by way of a share dividend, share split or in exchange for
or in replacement or upon conversion of such shares or otherwise in connection with a combination of shares, recapitalization, merger, consolidation or other corporate reorganization). 

“Stockholders” means the Carlyle Stockholders and any other shareholders who from time to time become party to this Agreement
by execution of a Joinder Agreement. 
 “Transfer” means any direct or indirect transfer, donation, sale, assignment,
pledge, hypothecation, grant of a security interest in or other disposal or attempted disposal of all or any portion of a security, any interest or rights in a security, or any rights under this Agreement. 

“Transferee” means the recipient of a Transfer. 

“WKSI” means a well-known seasoned issuer, as defined in the SEC’s Rule 405. 

SECTION II. REPRESENTATIONS AND WARRANTIES 

2.1 Representations and Warranties of the Initial Carlyle Stockholders. Each of the Initial Carlyle Stockholders hereby
represents, warrants and covenants to the Company as follows: (a) such Initial Carlyle Stockholder has full limited partnership, limited company or other corporate power and authority to enter into this Agreement and perform its obligations
hereunder; (b) this Agreement constitutes the valid and binding obligation of such Initial Carlyle Stockholder enforceable against it in accordance with its terms; and (c) the execution, delivery and performance by such Initial Carlyle
Stockholder of this Agreement: (i) does not and will not violate any laws, rules or regulations of the United States or any state or other jurisdiction applicable to such Initial Carlyle Stockholder, or require such Initial Carlyle Stockholder
to obtain any approval, consent or waiver of, or to make any filing with, any Person that has not been obtained or made; and (ii) does not constitute a breach of or default under any material agreement to which such Initial Carlyle Stockholder
is a party. 
 2.2 [Reserved.] 

2.3 Representations and Warranties of the Company. The Company hereby represents, warrants and covenants to the Stockholders as
follows: (a) the Company has full corporate power and authority to enter into this Agreement and perform its obligations hereunder; (b) this Agreement constitutes the valid and binding obligation of the Company enforceable against it in
accordance with its terms; and (c) the execution, delivery and performance by the Company of this Agreement: (i) does not and will not violate any laws, rules or regulations of the United States or any state or other jurisdiction
applicable to the Company, or require the Company to obtain any approval, consent or waiver of, or to make any filing with, any Person that has not been obtained or made; and (ii) does not and will not result in a breach of, constitute a
default under, accelerate any obligation under or give rise to a right of termination of any indenture or loan or credit agreement or any other material agreement, contract, instrument, mortgage, lien, lease, permit, authorization, order, writ,
judgment, injunction, decree, determination or arbitration award to which the Company is a party or by which the property of the Company is bound or affected, or result in the creation or imposition of any mortgage, pledge, lien, security interest
or other charge or encumbrance on any of the assets or properties of the Company. 

  
 4 













 SECTION III. BOARD MATTERS 

3.1 Board of Directors. From and after the first business day after the Effective Date: 

(a) Rights to Designate. Each Stockholder hereby agrees to vote, or cause to be voted, all of its Shares, at any annual or general
meeting, by written consent, or otherwise, and will take all Necessary Actions within such Stockholder’s control, and the Company will take all Necessary Actions within its control, to cause the authorized number of directors on the Board of
Directors to be established and remain at eleven, or such other number approved pursuant to the terms of this Agreement, and to elect or appoint or cause to be elected or appointed to the Board of Directors and cause to be continued in office: 

(i) ten designees of the Carlyle Stockholders constituting a Carlyle Majority Interest (the “Investor
Designees”); provided, that (A) the number of Investor Designees to be designated by the Carlyle Majority Interest (on behalf of the Carlyle Stockholders) shall be reduced to six Directors at such time as the Carlyle
Stockholders in the aggregate hold less than thirty-five percent (35%) of the then outstanding shares of Common Stock, (B) the number of Investor Designees to be designated by the Carlyle Majority Interest (on behalf of the Carlyle
Stockholders) shall be reduced to four Directors at such time as the Carlyle Stockholders in the aggregate hold less than twenty-five percent (25%) of the then outstanding shares of Common Stock, (C) the number of Investor Designees to be
designated by the Carlyle Majority Interest (on behalf of the Carlyle Stockholders) shall be reduced to two Directors at such time as the Carlyle Stockholders in the aggregate hold less than fifteen-percent (15%) of the then outstanding shares of
Common Stock, and (D) the Carlyle Stockholders shall have no right to designate any members of the Board of Directors pursuant to this Section 3.1(a)(i) at such time as the Carlyle Stockholders in the aggregate hold less than five percent
(5%) of the then-outstanding shares of Common Stock; 
 (ii) the senior ranking executive officer of the Company and its
subsidiaries, who initially, and for so long as he is the Company’s Chief Executive Officer, shall be Geoff Wild; and 

(iii) other than as set forth in this Agreement, each additional designee shall be filled as provided in the Articles. 

The Company shall take all Necessary Actions within its control to cause the individuals designated in accordance with Section 3.1(a) to be nominated for
election to the Board of Directors, shall solicit proxies in favor thereof, and at any meeting of the shareholders of the Company (if any is required) at which directors of the Company are to be elected, shall recommend that the shareholders of the
Company elect to the Board of Directors each such individual nominated for election at such meeting. 
 (b) Initial Investor
Designees. The initial Investor Designees pursuant to the provisions of Section 3.1(a)(i) shall be Brian A. Bernasek, Gregor P. Boehm, Herman H. Chang, Friedel Drees, Shaun Mercer, Gregory M. Nikodem, Charles W. Shaver and Martin W. Sumner.
Any remaining undesignated Investor Designees shall be designated by the Carlyle Majority Interest at such time as they shall determine. 

(c) Removal and Replacement. 

(i) Any Person or group of Persons entitled to designate a Director may remove such designee by sending a written notice to the
Company’s Secretary stating the name of the designee to be removed from the Board of Directors (the “Removal Notice”) and, upon receipt of such notice by the Company’s Secretary, such designee shall be removed from the
Board of Directors (and such a designee shall only be removed in such manner), and each Stockholder hereby agrees to vote, at any annual or special meeting, by written consent, or otherwise, all Shares and will take all Necessary Actions within such
Stockholder’s control to effect such removal. 

  
 5 













 (ii) If at any time any Director ceases to serve on the Board of Directors
(whether due to death, disability, resignation, removal or otherwise), the Person or Persons that designated or nominated such Director pursuant to Section 3.1(a) shall designate or nominate a successor to fill the vacancy created thereby on
the terms and subject to the conditions of Section 3.1(a). Each Stockholder hereby agrees to vote, or cause to be voted, all of its Shares, and will take all Necessary Actions within such Stockholder’s control, and the Company will take
all Necessary Actions within its control, to cause the designated successor to be elected to fill such vacancy. In the event that the Carlyle Stockholders do not, pursuant to Section 3.1(a), have the right to designate an individual to fill
such vacancy, then such vacancy shall be filled as provided in the Articles. 
 (iii) In the event that the Carlyle
Stockholders cease to have the right to designate an individual to serve as a Director pursuant to Section 3.1(a), (i) that number of Directors for which the Carlyle Stockholders cease to have the right to designate to serve as Directors shall
resign upon the expiry of such Directors’ term of service on the Board of Directors in order of expiry (each a “Departing Director”), provided that (A) in lieu of
the resignation of any such Departing Director (each a “Carlyle Continuing Director”), the Carlyle Stockholders may instead designate any other Director previously designated by the Carlyle Stockholders to resign at the expiration
of the original Departing Director’s term, with such Carlyle Continuing Director continuing as a Director, with the Company taking all Necessary Actions to ensure that such Carlyle Continuing Director be nominated for election to the Board of
Directors for an additional term and (B) if multiple Directors terms of service on the Board of Directors expire simultaneously, the Carlyle Stockholders may designate which such Director shall resign, and (ii) the vacancy created by such
resignation or removal shall be filled as provided in the Articles. 
 (d) Expenses. Each Director shall be entitled to reimbursement
from the Company for his or her reasonable out-of-pocket expenses (including travel) incurred in attending any meeting of the Board of Directors or any committee thereof
or governing body of any subsidiary of the Company or any committee thereof. 
 (e) Indemnification; Insurance. The Company shall not
alter, in any manner adverse to the Investor Designees, any rights to indemnification and exculpation from liabilities currently afforded to members of the Board of Directors, provided they are permitted by applicable law, pursuant to the Articles
or any indemnification agreement, in each case, as in effect as of the Effective Date. If the Company or any of its respective successors or assigns (i) shall consolidate with or merge into any other corporation or entity and shall not be the
continuing or surviving corporation or entity of such consolidation or merger or (ii) shall transfer all or substantially all of its properties and assets to any individual, corporation or other entity, then, and in each such case, proper
provisions shall be made so that the successors and assigns of the Company shall covenant to afford to each of the Investor Designees such rights to indemnification and exculpation from liabilities. To the fullest extent permitted by applicable law,
the Company shall continue to maintain in effect directors’ and officers’ liability insurance and fiduciary liability insurance with benefits, terms, conditions, retentions and levels of coverage that are at least as favorable, in the
aggregate, to the insureds as provided in the Company’s existing policies as of the Effective Date. 
 3.2 Committees of the
Board of Directors. From and after the Effective Date, the Company shall, and each Stockholder shall use its reasonable best efforts to, cause the Board of Directors to establish and maintain the following committees: (a) an Audit
Committee, (b) a Compensation Committee, (c) a Nominating and Corporate Governance Committee, (d) an Executive Committee and (e) any other committee needed to comply with applicable laws and regulations and (d) any other
committee as the Board of Directors shall determine in its discretion. Each committee shall include such number of Investor Designees such that the pro rata representation of the Investor Designees on such committee as a proportion


  
 6 













 
of the full membership of such committee is not less than the pro rata representation of all of the Investor Designees as a proportion of the full Board of Directors; provided that the
right of any such Investor Designee to serve on a committee shall be subject to the Company’s obligation to comply with any applicable independence requirements of a national securities exchange upon which the Company’s Common Stock is
listed to which it is then subject. 
 3.3 Additional Management Provisions. 

(a) Each Stockholder and the Company agrees and acknowledges that, subject to applicable law, the Investor Designees designated by the Carlyle
Majority Interest may share confidential, non-public information about the Company and its subsidiaries with the Carlyle Stockholders, their Permitted Transferees and their respective Affiliates, directors and
officers. 
 (b) The Stockholders and the Company hereby agree, notwithstanding anything to the contrary in any other agreement or at law or
in equity, that, to the maximum extent permitted by applicable law, when the Carlyle Stockholders take any action under this Agreement to give or withhold its consent, the Carlyle Stockholders shall have no duty (fiduciary or other) to consider the
interests of the Company or the other Stockholders and may act exclusively in its own interest; provided, however, that the foregoing shall in no way affect the obligations of the parties hereto to comply with the provisions of this
Agreement. 
 (c) Each of the parties covenants and agrees to take all Necessary Actions within its control to ensure that the Articles and
Memorandum of Association do not, at any time, conflict with the provisions of this Agreement. 
 (d) For so long as the Company qualifies
as a “controlled company” under the applicable listing standards then in effect, the Company will elect to be a “controlled company” for purposes of such applicable listing standards, and will disclose in its annual meeting proxy
statement that it is a “controlled company” and the basis for that determination. The Company and the Stockholders acknowledge and agree that, as of the date of this Agreement, the Company is a “controlled company.” The Carlyle
Stockholders acknowledge that a sufficient number of their designees will be required to qualify as “independent directors” to ensure that the Board complies with such applicable listing standards in the time periods required by the
applicable listing standards then in effect, and shall discuss and use commercially reasonable efforts to agree upon appropriate changes to their designees consistent with the foregoing. 

3.4 Company. The Company will not give effect to any action by any Stockholder which is in contravention of this Section III. 

SECTION IV. REGISTRATION RIGHTS 
 4.1
Demand and Piggyback Rights. 
 (a) Right to Demand a Non-Shelf Registered Offering.
Upon the demand of at any time and from time to time after the expiration or waiver of the underwriter lock-up period applicable to the Company’s IPO, the Company will facilitate in the manner described
in this Agreement a non-shelf registered offering of the Shares requested by the demanding Carlyle Stockholders to be included in such offering. A demand by Carlyle Stockholders for a non-shelf registered offering that will result in the imposition of a lockup on the Company and the Stockholders may not be made unless the Shares requested to be sold by the demanding Carlyle Stockholders in such
offering have an aggregate market value (based on the most recent closing price of the Common Stock at the time of the demand) of at least $50 million or such lesser amount if all Shares held by the demanding Carlyle Stockholders are requested
to be sold. 

  
 7 













 
Subject to Section 4.2(e) below, any demanded non-shelf registered offering may, at the Company’s option, include Shares to be sold by the
Company for its own account and will also include Shares to be sold by other holders of Shares with similar rights that exercise their related piggyback rights on a timely basis. 

(b) Right to Piggyback on a Non-Shelf Registered Offering. In connection with any registered
offering of Common Stock covered by a non-shelf registration statement, the Carlyle Stockholders may exercise piggyback rights to have included in such offering Shares held by them. The Company will facilitate
in the manner described in this Agreement any such non-shelf registered offering. 
 (c) Right to
Demand and be Included in a Shelf Registration. Upon the demand of any Carlyle Stockholder (any such demand, together with any demand pursuant to Section 4.1(a), a “demand registration”, made at any time and from time to
time when the Company is eligible to utilize Form S-3 or a successor form to sell Shares in a secondary offering on a delayed or continuous basis in accordance with Rule 415, the Company will facilitate in the
manner described in this Agreement a shelf registration of Shares held by the Carlyle Stockholders. Any shelf registration filed by the Company covering Shares (whether pursuant to a Carlyle Stockholder demand or at the initiative of the Company)
will cover Shares held by each of the Carlyle Stockholders (regardless of whether they demanded the filing of such shelf or not) up to an equivalent percentage of their original respective holdings as may be agreed upon by the demanding Carlyle
Stockholders unless otherwise requested by any such Carlyle Shareholder. If at the time of such request the Company is a WKSI, such shelf registration would, at the request of such Carlyle Stockholders, cover an unspecified number of Shares to be
sold by the Company and the Carlyle Stockholders. 
 (d) Demand and Piggyback Rights for Underwritten Offerings. Upon the demand of
one or more Carlyle Stockholders made at any time and from time to time, the Company will facilitate in the manner described in this Agreement a “takedown” of Shares off of an effective shelf registration statement or inclusion in any non-shelf registration statement proposed to be filed by the Company. In connection with any underwritten offering (whether pursuant to the exercise of such demand rights or at the initiative of the Company), the
Carlyle Stockholders may exercise piggyback rights (any such registration, a “piggyback registration”) to have included in such registration statement Shares held by them and include any such shares in any underwritten offering
pursuant to such registration statement. Notwithstanding the foregoing, Carlyle Stockholders may not demand a shelf takedown for an offering or inclusion in a non-shelf offering that will result in the
imposition of a lockup on the Company and the Stockholders unless the Shares requested to be sold by the demanding Carlyle Stockholders in such takedown have an aggregate market value (based on the most recent closing price of the Common Stock at
the time of the demand) of at least $50 million or such lesser amount if all Shares held by the demanding Carlyle Stockholders are requested to be sold. 

(e) Right to Reload a Shelf. Upon the written request of a Carlyle Stockholder, the Company will file and seek the effectiveness of a
post-effective amendment to an existing shelf in order to register up to the number of Shares previously taken down off of such shelf and not yet “reloaded” onto such shelf. 

(f) Limitations on Demand and Piggyback Rights. 

(i) Any demand for the filing of a registration statement or for a registered offering or takedown will be subject to the
constraints of any applicable lockup arrangements, and such demand must be deferred until such lockup arrangements no longer apply. If a demand has been made for a non-shelf registered offering or for an
underwritten takedown, no further demands may be made so long as the related offering is still being pursued. Notwithstanding anything in this Agreement to the contrary, the Carlyle Stockholders will not have piggyback or other registration


  
 8 













 
rights with respect to registered primary offerings by the Company (i) covered by a Form S-8 registration statement or a successor form applicable to
employee benefit-related offers and sales, (ii) where the Shares are not being sold for cash or (iii) where the offering is a bona fide offering of securities other than Shares, even if such securities are convertible into or exchangeable
or exercisable for Shares. 
 (ii) The Company may postpone the filing of a demanded registration statement or suspend the
effectiveness of any shelf registration statement for a reasonable “blackout period” not in excess of 90 days if such registration or offering would require the Company to make an Adverse Disclosure; provided that the Company shall not
postpone the filing of a demanded registration statement or suspend the effectiveness of any shelf registration statement pursuant to this Section 4.1(f)(ii) more than once in any 360 day period. The blackout period will end upon the earlier to
occur of, (i) in the case of a bona fide business or financing transaction, a date not later than 90 days from the date such deferral commenced, and (ii) in the case of an Adverse Disclosure, the earlier to occur of (x) the filing by
the Company of its next succeeding Form 20-F or quarterly report on Form 6-K, or (y) the date upon which such information is otherwise disclosed. 

4.2 Notices, Cutbacks and Other Matters. 

(a) Notifications Regarding Registration Statements. In order for one or more Carlyle Stockholders to exercise their right to demand
that a registration statement be filed, they must so notify the Company in writing indicating the number of Shares sought to be registered and the proposed plan of distribution. The Company will keep the Carlyle Stockholders contemporaneously
apprised of all pertinent aspects of its pursuit of any registration, whether pursuant to a Carlyle Stockholder demand or otherwise, with respect to which a piggyback opportunity is available. Pending any required public disclosure and subject to
applicable legal requirements, the parties will maintain the confidentiality of these discussions. 
 (b) Notifications Regarding
Registration Piggyback Rights. Any Carlyle Stockholder wishing to exercise its piggyback rights with respect to a non-shelf registration statement must notify the Company and the other Carlyle Stockholders
of the number of Shares it seeks to have included in such registration statement. Such notice must be given as soon as practicable, but in no event later than 5:00 pm, New York City time, on the second trading day prior to (i) if applicable,
the date on which the preliminary prospectus intended to be used in connection with pre-effective marketing efforts for the relevant offering is expected to be finalized, and (ii) in any case, the date on
which the pricing of the relevant offering is expected to occur. 
 (c) Notifications Regarding Underwritten Offerings. 

(i) The Company will keep the Carlyle Stockholders contemporaneously apprised of (including prompt notice of its intention to
conduct any offering of securities) all pertinent aspects of any underwritten offering in order that they may have a reasonable opportunity to exercise their related piggyback rights. Without limiting the Company’s obligation as described in
the preceding sentence, having a reasonable opportunity requires that the Carlyle Stockholders be notified by the Company of an anticipated underwritten offering no later than 5:00 pm, New York City time, on (i) if applicable, the second
trading day prior to the date on which the preliminary prospectus or prospectus supplement intended to be used in connection with pre-pricing marketing efforts for such takedown is finalized, and (ii) in
all cases, the second trading day prior to the date on which the pricing of the relevant takedown occurs. 
 (ii) Any Carlyle
Stockholder wishing to exercise its piggyback rights with respect to an underwritten offering must notify the Company and the other Carlyle Stockholders of 

  
 9 













 
the number of Shares it seeks to have included in such offering. Such notice must be given as soon as practicable, but in no event later than 5:00 pm, New York City time, on (i) if
applicable, the trading day prior to the date on which the preliminary prospectus or prospectus supplement intended to be used in connection with marketing efforts for the relevant offering is expected to be finalized, and (ii) in all cases,
the trading day prior to the date on which the pricing of the relevant takedown occurs. 
 (iii) Pending any required public
disclosure and subject to applicable legal requirements, the parties will maintain appropriate confidentiality of their discussions regarding a prospective underwritten takedown. 

(d) Plan of Distribution, Underwriters and Counsel. If (1) a majority of the Shares proposed to be sold in an underwritten
offering through a non-shelf registration statement or through a shelf takedown are being sold by the Company for its own account and (2) such offering was initiated by the Company and not by any Carlyle
Stockholder pursuant to Section 4.1 or 4.2, the Company will be entitled to determine the plan of distribution and select the managing underwriters for such offering. Otherwise, the Carlyle Stockholders will be entitled to determine the plan of
distribution and select the managing underwriters, and such Carlyle Stockholders will also be entitled to select counsel for the selling Stockholders (which may be the same as counsel for the Company). In the case of a shelf registration statement,
the plan of distribution will provide as much flexibility as is reasonably possible, including with respect to resales by transferee Stockholders. 

(e) Cutbacks. If the managing underwriters advise the Company and the selling Stockholders that, in their opinion, the number of Shares
requested to be included in an underwritten offering exceeds the amount that can be sold in such offering without adversely affecting the distribution of the Shares being offered, such offering will include only the number of Shares that the
underwriters advise can be sold in such offering. 
 (i) In the case of a registered offering upon the demand of one or more
Carlyle Stockholders, the selling Stockholders (including those Carlyle Stockholders exercising piggyback rights pursuant to Section 4.1(b)) collectively will have first priority and will be subject to cutback pro rata based on the Initial
Capital Interest of each such selling Stockholder (up to the number of Shares initially requested by them to be included in such offering). To the extent of any remaining capacity, all other shareholders having similar registration rights will have
second priority and will be subject to cutback pro rata based on the number of Shares initially requested by them to be included in such offering. To the extent of any remaining capacity, the Company will have third priority. Except as contemplated
by the immediately preceding three sentences, other selling shareholders (other than transferees to whom a Carlyle Stockholder has assigned its rights under this Agreement) will be included in an underwritten offering only with the consent of
Carlyle Stockholders holding a majority of the Shares being sold in such offering. 
 (ii) In the case of a registered
offering upon the initiative of the Company, the Company will have first priority. To the extent of any remaining capacity, the selling Carlyle Stockholders as a group, on the one hand, and all other shareholders having similar registration rights
as a group, on the other hand, will be subject to cutback pro rata based on the number of Shares initially requested by such group to be included in such offering. The selling Carlyle Stockholders will be subject to cutback pro rata, based on the
Initial Capital Interest of each such selling Carlyle Stockholder (up to the number of Shares initially requested by them to be included in such offering). Except as contemplated by the second preceding sentence, other shareholders (other than
transferees to whom a Carlyle Stockholder has assigned its rights under this Agreement) will be included in an underwritten offering only with the consent of a Carlyle Majority Interest. 

  
 10 













 (f) Withdrawals. Even if Shares held by a Carlyle Stockholder have been part of a
registered underwritten offering (pursuant to either demand or piggyback rights), such Carlyle Stockholder may, no later than the time at which the public offering price and underwriters’ discount are determined with the managing underwriter,
decline to sell all or any portion of the Shares being offered for its account. 
 (g) Lockups. In connection with any underwritten
offering of Shares, the Company and each Carlyle Stockholder will agree (in the case of Carlyle Stockholders, with respect to Shares respectively held by them) to be bound by the underwriting agreement’s lockup restrictions (which must apply,
and continue to apply, in like manner to all of them) that are agreed to (a) by the Company, if (1) a majority of the Shares being sold in such offering are being sold for its account and (2) such offering was initiated by the Company
and not by any Carlyle Stockholder pursuant to Section 4.1 or 4.2, or (b) by Carlyle Stockholders holding a majority of Shares being sold by all Carlyle Stockholders, if a majority of the Shares being sold in such offering are being sold
by Carlyle Stockholders, as applicable. 
 (h) Expenses. All expenses incurred in connection with any registration statement or
registered offering covering Shares held by Carlyle Stockholders, including, without limitation, all registration and filing fees, printing (including printing certificates for the Shares in a form eligible for deposit with the Depository Trust
Company and printing preliminary, supplemental and final prospectuses) expenses, word processing, duplicating, telephone and facsimile expenses, messenger and delivery expenses, transfer taxes, expenses incurred in connection with promotional
efforts or “roadshows”, fees and disbursements of counsel (including the fees and disbursements of outside counsel for Carlyle Stockholders and fees and disbursements of counsel to the underwriters with respect to “blue sky”
qualification of such Shares and their determination for eligibility for investment under the laws of the various jurisdictions (up to the cap on such fees included in any applicable underwriting agreement)) and of the independent certified public
accountants (including with respect to the preparation of customary financial statements required to be included in any offering document, the provision of any customary comfort letters and any the conduct of special audits required by, or
incidental to, such registration), and the expense of qualifying such Shares under state blue sky laws and foreign securities laws, will be borne by the Company. However, underwriters’, brokers’ and dealers’ discounts and commissions
applicable to Shares sold for the account of a Carlyle Stockholder will be borne by such Carlyle Stockholder. 
 4.3 Facilitating
Registrations and Offerings. 
 (a) General. If the Company becomes obligated under this Agreement to facilitate a registration
and offering of Shares on behalf of Carlyle Stockholders, the Company will do so with the same degree of care and dispatch as would reasonably be expected in the case of a registration and offering by the Company of Shares for its own account.
Without limiting this general obligation, the Company will fulfill its specific obligations as described in this Section 4.3. 
 (b)
Registration Statements. In connection with each registration statement that is demanded by Carlyle Stockholders or as to which piggyback rights otherwise apply, the Company will: 

(i) (A) prepare and file (or confidentially submit) with the SEC a registration statement covering the applicable Shares,
(B) prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for a period ending when all of
the securities covered by such registration statement have been disposed of in accordance with the intended methods of distribution by the sellers thereof set forth in such registration statement (but not in any event before the expiration of any
longer period required under the Securities Act or, if such registration statement relates to an underwritten public offering, such longer period as in the opinion of counsel for the underwriters a prospectus is required by law to be delivered in
connection 

  
 11 













 
with the sale of Shares by an underwriter or dealer), (C) seek the effectiveness thereof, (D) file with the SEC prospectuses and prospectus supplements as may be required, all in
consultation with the Carlyle Stockholders and as reasonably necessary in order to permit the offer and sale of the such Shares in accordance with the applicable plan of distribution, and (E) make any analogous filings with the JFSC as may be
required for the purposes of obtaining any Jersey Consents to facilitate the circulation of any prospectuses and prospectus supplements as may be required in accordance with this Section 4.3; 

(ii) (1) within a reasonable time prior to the filing of any registration statement, any prospectus, any amendment to a registration
statement, amendment or supplement to a prospectus or any free writing prospectus, provide copies of such documents to the selling Carlyle Stockholders and to the underwriter or underwriters of an underwritten offering, if applicable, and to their
respective counsel; fairly consider such reasonable changes in any such documents prior to or after the filing thereof as the counsel to the Carlyle Stockholders or the underwriter or the underwriters may request; and make such of the
representatives of the Company as shall be reasonably requested by the selling Carlyle Stockholders or any underwriter available for discussion of such documents; 

(2) within a reasonable time prior to the filing of any document which is to be incorporated by reference into a registration statement or a
prospectus, provide copies of such document to counsel for the Carlyle Stockholders and underwriters; fairly consider such reasonable changes in such document prior to or after the filing thereof as counsel for such Carlyle Stockholders or such
underwriter shall request; and make such of the representatives of the Company as shall be reasonably requested by such counsel available for discussion of such document; 

(iii) cause each registration statement and the related prospectus and any amendment or supplement thereto, as of the effective
date of such registration statement, amendment or supplement and during the distribution of the registered Shares (x) to comply in all material respects with the requirements of the Securities Act, the rules and regulations of the SEC, and the
JFSC and (y) not to contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; 

(iv) notify each Carlyle Stockholder promptly, and, if requested by such Carlyle Stockholder, confirm such advice in writing,
(A) when a registration statement has become effective and when any post-effective amendments and supplements thereto become effective if such registration statement or post-effective amendment is not automatically effective upon filing
pursuant to Rule 462, (B) of the issuance by the SEC or any state or foreign securities authority of any stop order, injunction or other order or requirement suspending the effectiveness of a registration statement or the initiation or threatening
of any proceedings for that purpose, (C) if, between the effective date of a registration statement and the closing of any sale of securities covered thereby pursuant to any agreement to which the Company is a party, the representations and
warranties of the Company contained in such agreement cease to be true and correct in all material respects or if the Company receives any notification with respect to the suspension of the qualification of the Shares for sale in any jurisdiction or
the initiation or threatening of any proceeding for such purpose, and (D) of the happening of any event during the period a registration statement is effective as a result of which such registration statement or the related prospectus contains
any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, if required by applicable law, prepare and file a supplement or amendment to
such registration statement or prospectus so that, as thereafter delivered to the purchasers of Shares registered thereby, such registration statement or prospectus will not contain an untrue statement of a material fact or omit to state any fact
necessary to make the statements therein not misleading; 

  
 12 













 (v) furnish counsel for each underwriter, if any, and for the Carlyle
Stockholders copies of any correspondence with the SEC, the JFSC or any state securities authority relating to the registration statement or prospectus; 

(vi) otherwise comply with all applicable rules and regulations of the SEC and JFSC, including making available to its security
holders an earnings statement covering at least 12 months which shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any similar provision then in force); 

(vii) use all reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of a registration statement
at the earliest possible time; 
 (c) Non-Shelf Registered Offerings and Shelf Takedowns. In
connection with any non-shelf registered offering or shelf takedown that is demanded by Carlyle Stockholders or as to which piggyback rights otherwise apply, the Company will: 

(i) cooperate with the selling Carlyle Stockholders Shares and the sole underwriter or managing underwriter of an underwritten
offering Shares, if any, to facilitate the timely preparation and delivery of certificates representing the Shares to be sold and not bearing any restrictive legends; and enable such Shares to be in such denominations (consistent with the provisions
of the governing documents thereof) and registered in such names as the selling Carlyle Stockholders or the sole underwriter or managing underwriter of an underwritten offering of Shares, if any, may reasonably request at least five days prior to
any sale of such Shares; 
 (ii) subject always to applicable laws, furnish to each Carlyle Stockholder and to each
underwriter, if any, participating in the relevant offering, without charge, as many copies of the applicable prospectus, including each preliminary prospectus or prospectus supplement, and any amendment or supplement thereto and such other
documents as such Carlyle Stockholder or underwriter may reasonably request in order to facilitate the public sale or other disposition of the Shares; the Company hereby consents to the use of the prospectus, including each preliminary prospectus or
prospectus supplement, by each such Carlyle Stockholder and underwriter in connection with the offering and sale of the Shares covered by the prospectus, preliminary prospectus or prospectus supplement; 

(iii) (A) use all reasonable efforts to register or qualify the Shares being offered and sold, no later than the time the
applicable registration statement becomes effective, under all applicable state securities or “blue sky” laws of such jurisdictions as each underwriter, if any, or any Carlyle Stockholder holding Shares covered by a registration statement,
shall reasonably request; (B) use all reasonable efforts to keep each such registration or qualification effective during the period such registration statement is required to be kept effective; (C) comply with the provisions of the
Securities Act with respect to the disposition of all securities covered by such registration statement during such period in accordance with the intended methods of disposition by the sellers thereof set forth in the registration statement and
(D) do any and all other acts and things which may be reasonably necessary or advisable to enable each such underwriter, if any, and Carlyle Stockholder to consummate the disposition in each such jurisdiction of such Shares owned by such
Carlyle Stockholder; provided, however, that the Company shall not be obligated to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified


  
 13 













 
or to consent to be subject to general service of process (other than service of process in connection with such registration or qualification or any sale of Shares in connection therewith) in
any such jurisdiction where it would not otherwise be required to qualify but for this subparagraph (D) or subject itself to taxation in any such jurisdiction; 

(iv) (A) cause all Shares being sold to be qualified for inclusion in or listed on The New York Stock Exchange or any other
U.S. securities exchange on which Shares issued by the Company are then so qualified or listed if so requested by the Carlyle Stockholders, or if so requested by the underwriter or underwriters of an underwritten offering of Shares, if any, and
arrange for at least two market makers to register as such with respect to the Shares with the Financial Industry Regulatory Authority (“FINRA”), (B) comply (and continue to comply) with the requirements of any self-regulatory
organization applicable to the Company, including without limitation all corporate governance requirements, (C) use its best efforts to cause Shares covered by such registration statement to be registered with or approved by such other
governmental agencies or authorities as may be necessary to enable the sellers thereof to consummate the disposition of such Shares and (D) use best efforts to provide a transfer agent and registrar for all Shares to be sold by the Carlyle
Stockholders not later than the effective date of such registration statement; 
 (v) cooperate and assist in any filings
required to be made with FINRA and in the performance of any due diligence investigation by any underwriter in an underwritten offering; 

(vi) use all reasonable efforts to facilitate the distribution and sale of any Shares to be offered pursuant to this Agreement,
including without limitation by making road show presentations, holding meetings with and making calls to potential investors and taking such other actions as shall be requested by the Carlyle Stockholders or the lead managing underwriter of an
underwritten offering; 
 (vii) enter into customary agreements (including, in the case of an underwritten offering,
underwriting agreements in customary form, and including provisions with respect to indemnification and contribution in customary form and consistent with the provisions relating to indemnification and contribution contained herein) and take all
other customary and appropriate actions in order to expedite or facilitate the disposition of such Shares in connection therewith, including: 

(1) make such representations and warranties to the selling Stockholders and the underwriters, if any, in form, substance and scope as are
customarily made by issuers to underwriters in similar underwritten offerings; 
 (2) obtain opinions of counsel to the Company in all
relevant jurisdictions and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the lead managing underwriter, if any) addressed to the underwriters, if any, covering the matters and
jurisdictions customarily covered in opinions requested in sales of securities or underwritten offerings and such other matters as may be reasonably requested by such Stockholders and underwriters; 

(3) obtain “cold comfort” letters and updates thereof from the Company’s independent certified public accountants addressed to
the underwriters, if any, which letters shall be customary in form and shall cover matters of the type customarily covered in “cold comfort” letters to underwriters in connection with primary underwritten offerings; 

  
 14 













 (4) to the extent requested and customary for the relevant transaction, enter into a
securities sales agreement with the Carlyle Stockholders providing for, among other things, the appointment of such representative as agent for the selling Carlyle Stockholders for the purpose of soliciting purchases of Shares, which agreement shall
be customary in form, substance and scope and shall contain customary representations, warranties and covenants. 
 The above shall be done
at such times as customarily occur in similar registered offerings or shelf takedowns. 
 (viii) take all actions to ensure
that any free-writing prospectus utilized in connection with any demand registration or piggyback registration or shelf offering hereunder complies in all material respects with the Securities Act and the laws of Jersey in relation to the
circulation of a prospectus, is filed in accordance with the Securities Act and the laws of Jersey to the extent required thereby, is retained in accordance with the Securities Act and the laws of Jersey to the extent required thereby and, when
taken together with the related prospectus, prospectus supplement and related documents, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading; 
 (ix) permit any Carlyle Stockholder that, in its sole exclusive
judgment, might be deemed to be an underwriter or a controlling person of the Company, to participate in the preparation of such registrations statement or comparable statement and to allow such Carlyle Stockholder to provide language for insertion
therein, in form and substance satisfactory to the Company, which in the reasonable judgment of such Carlyle Stockholder and its counsel should be included; 

(x) use best efforts to (A) make Form S-3 available for the sale of Shares and
(B) prevent the issuance of any stop order suspending the effectiveness of a registration statement, or the issuance of any order suspending or preventing the use of any related prospectus or suspending the qualification of any Shares included
in such registration statement for sale in any jurisdiction, and in the event any such order is issued, use best efforts to obtain promptly the withdrawal of such order; 

(xi) if requested by any managing underwriter and reasonably available, include in any prospectus or prospectus supplement
updated financial or business information for the Company’s most recent period or current quarterly period (including estimated results or ranges of results) if required for purposes of marketing the offering in the view of the managing
underwriter; 
 (xii) take no direct or indirect action prohibited by Regulation M under the Exchange Act, provided, however,
that to the extent any prohibition is applicable to the Company, the Company will take such action as is necessary to make any such prohibition inapplicable; 

(xiii) cooperate with each Carlyle Stockholder covered by the registration statement and each underwriter or agent
participating in the disposition of such Shares and their respective counsel in connection with the preparation and filing of applications, notices, registrations and responses to requests for additional information with FINRA, the New York Stock
Exchange, Nasdaq, the JFSC or any other national securities exchange on which the Shares are or are to be listed, and to the extent required by the rules and regulations of FINRA, retain a Qualified Independent Underwriter acceptable to the managing
underwriter; 

  
 15 













 (xiv) if the Company files an automatic shelf registration statement
covering any Shares, use its best efforts to remain a WKSI (and not become an ineligible issuer (as defined in Rule 405 under the Securities Act)) during the period during which such Automatic Shelf Registration Statement is required to remain
effective; 
 (xv) if the Company does not pay the filing fee covering the Shares at the time an automatic shelf registration
statement is filed, pay such fee at such time or times as the Shares are to be sold; and 
 (xvi) if the automatic shelf
registration statement has been outstanding for at least three years, at the end of the third year, refile a new automatic shelf registration statement covering the Shares, and, if at any time when the Company is required to re-evaluate its WKSI status the Company determines that it is not a WKSI, use its best efforts to refile the shelf registration statement on Form S-3 and, if such form is not
available, Form S-1 and keep such registration statement effective during the period during which such registration statement is required to be kept effective. 

(d) Due Diligence. In connection with each registration and offering of Shares to be sold by Carlyle Stockholders, the Company will, in
accordance with customary practice, make available for inspection by representatives of the Carlyle Stockholders and underwriters and any counsel or accountant retained by such Carlyle Stockholder or underwriters all relevant financial and other
records, pertinent corporate documents and properties of the Company and cause appropriate officers, managers and employees of the Company to supply all information reasonably requested by any such representative, underwriter, counsel or accountant
in connection with their due diligence exercise. 
 (e) Information from Stockholders. Each Carlyle Stockholder that holds Shares
covered by any registration statement will furnish to the Company such information regarding itself as is required to be included in the registration statement, the ownership of Shares by such Carlyle Stockholder and the proposed distribution by
such Carlyle Stockholder of such Shares as the Company may from time to time reasonably request in writing. 
 (f) If the Company files any
automatic shelf registration statement for the benefit of the holders of any of its securities other than the Carlyle Stockholders, and the Carlyle Stockholders do not request that their Shares be included in such shelf registration statement, the
Company agrees that, at the request of the Carlyle Majority Interest, it will include in such automatic shelf registration statement such disclosures as may be required by Rule 430B in order to ensure that the Carlyle Stockholders may be added to
such shelf registration statement at a later time through the filing of a prospectus supplement rather than a post-effective amendment. If the Company has filed any automatic shelf registration statement for the benefit of the holders of any of its
securities other than the Carlyle Stockholders, the Company shall, at the request of the Carlyle Majority Interest, file any post-effective amendments necessary to include therein all disclosure and language necessary to ensure that the Carlyle
Stockholders may be added to such Shelf Registration Statement. 
 4.4 Indemnification. 

(a) Indemnification by the Company. In the event of any registration under the Securities Act by any registration statement of Shares
held by Carlyle Stockholders, the Company will hold harmless Carlyle Stockholders, any such Carlyle Stockholder’s officers, directors, employees, agents, fiduciaries, shareholders, managers, partners, members, affiliates, direct and indirect
equityholders, consultants and representatives, and any successors and assigns thereof, and each underwriter of such securities and each other person, if any, who controls any Carlyle Stockholder or such underwriter within


  
 16 













 
the meaning of the Securities Act (collectively, the “Indemnified Parties”), against any losses, claims, actions, damages, liabilities or expenses (including with respect to
actions or proceedings, whether commenced or threatened, and including reasonable attorney fees and expenses) (collectively, “Losses”), joint or several, to which Carlyle Stockholders or such underwriter or controlling person may
become subject under the Securities Act or otherwise, insofar as such Losses arise out of or are based upon (i) any untrue or alleged untrue statement of material fact contained in (A) any registration statement, prospectus, preliminary
prospectus or Free-Writing Prospectus, or any amendment thereof or supplement thereto or (B) any application or other document or communication (in this Section 4.4, collectively called an “application”) executed by or on behalf
of the Company or based upon written information furnished by or on behalf of the Company filed in any jurisdiction in order to qualify any securities covered by such registration under the “blue sky” or securities laws thereof,
(ii) any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading or (iii) any violation or alleged violation by the Company of the Securities Act or any other
similar federal or state securities laws or any rule or regulation promulgated thereunder applicable to the Company and relating to action or inaction required of the Company in connection with any such registration, qualification or compliance; and
will reimburse any such Indemnified Person for any legal or any other expenses reasonably incurred by them in connection with investigating or defending any such Losses; provided, however, that the Company shall not be liable to any such Indemnified
Person in any such case to the extent that any such Losses arise out of or are based upon an untrue statement or alleged untrue statement or omission or alleged omission made in such registration statement, prospectus, preliminary prospectus or
free-writing prospectus or any amendment or supplement thereto, or in any application, in reliance upon and in conformity with information furnished to the Company through a written instrument duly executed by such Indemnified Person specifically
for use in the preparation thereof. 
 (b) Indemnification by Carlyle Stockholders. Each Carlyle Stockholder will indemnify and hold
harmless (in the same manner and to the same extent as set forth in Section 4.4(a)) the Company, its officers, directors, employees, agents and representatives, and each Person who controls the Company (within the meaning of the Securities
Act), with respect to Losses (as determined by a final and unappealable judgment, order or decree of a court of competent jurisdiction) arising from (i) any statement or omission from such registration statement, or any amendment or supplement
to it, if such statement or omission was made in reliance upon and in conformity with information furnished to the Company through a written instrument duly executed by such Carlyle Stockholder specifically regarding such Carlyle Stockholder for use
in the preparation of such registration statement or amendment or supplement, and (ii) compliance by such Carlyle Stockholder with applicable laws in effecting the sale or other disposition of the securities covered by such registration
statement. 
 (c) Indemnification Procedures. Promptly after receipt by an indemnified party of notice of the commencement of any
action involving a claim referred to in Section 4.4(a) and Section 4.4(b), the indemnified party will, if a resulting claim is to be made or may be made against and indemnifying party, give written notice to the indemnifying party of the
commencement of the action. The failure of any indemnified party to give notice shall not relieve the indemnifying party of its obligations in this Section 4.4, except to the extent that the indemnifying party is actually prejudiced by the
failure to give notice. If any such action is brought against an indemnified party, the indemnifying party will be entitled to participate in and to assume the defense of the action with counsel reasonably satisfactory to the indemnified party, and
after notice from the indemnifying party to such indemnified party of its election to assume defense of the action, the indemnifying party will not be liable to such indemnified party for any legal or other expenses incurred by the latter in
connection with the action’s defense. An indemnified party shall have the right to employ separate counsel in any action or proceeding and participate in the defense thereof, but the fees and expenses of such counsel shall be at such
indemnified party’s expense unless (i) the employment of such counsel has been specifically authorized in writing by the indemnifying party, which authorization shall not be unreasonably withheld, (ii) the indemnifying party has not
assumed the defense 

  
 17 













 
and employed counsel reasonably satisfactory to the indemnified party within 30 days after notice of any such action or proceeding, or (iii) the named parties to any such action or
proceeding (including any impleaded parties) include the indemnified party and the indemnifying party and the indemnified party shall have been advised by such counsel that there may be one or more legal defenses available to the indemnified party
that are different from or additional to those available to the indemnifying party (in which case the indemnifying party shall not have the right to assume the defense of such action or proceeding on behalf of the indemnified party), it being
understood, however, that the indemnifying party shall not, in connection with any one such action or separate but substantially similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances, be
liable for the reasonable fees and expenses of more than one separate firm of attorneys (in addition to all local counsel which is necessary, in the good faith opinion of both counsel for the indemnifying party and counsel for the indemnified party
in order to adequately represent the indemnified parties) for the indemnified party and that all such fees and expenses shall be reimbursed as they are incurred upon written request and presentation of invoices. Whether or not a defense is assumed
by the indemnifying party, the indemnifying party will not be subject to any liability for any settlement made without its consent (but such consent not to be unreasonably withheld). No indemnifying party will consent to entry of any judgment or
enter into any settlement which (i) does not include as an unconditional term the giving by the claimant or plaintiff, to the indemnified party, of a release from all liability in respect of such claim or litigation or (ii) involves the
imposition of equitable remedies or the imposition of any non-financial obligations on the indemnified party. 

(d) Contribution. If the indemnification required by this Section 4.4 from the indemnifying party is unavailable to or
insufficient to hold harmless an indemnified party in respect of any indemnifiable Losses, then the indemnifying party shall contribute to the amount paid or payable by the indemnified party as a result of such Losses in such proportion as is
appropriate to reflect (i) the relative benefit of the indemnifying and indemnified parties and (ii) if the allocation in clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect the relative
benefit referred to in clause (i) and also the relative fault of the indemnified and indemnifying parties, in connection with the actions which resulted in such Losses, as well as any other relevant equitable considerations. The relative fault
of the indemnifying party and the indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact, has been made by, or relates to
information supplied by, such indemnifying party or parties, and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the Losses
referred to above shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with any investigation or proceeding. The Company and Carlyle Stockholders agree that it would not be just and equitable
if contribution pursuant to this Section 4.4(d) were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the prior provisions of this
Section 4.4(d). Notwithstanding the provisions of this Section 4.4(d), no indemnifying party shall be required to contribute any amount in excess of the amount by which the net proceeds from the sale of the securities which were offered to
the public by the indemnifying party exceeds the amount of any damages which the indemnifying party has otherwise been required to pay by reason of an untrue statement or omission. No person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such a fraudulent misrepresentation. 

(e) Non-Exclusive Remedy(f) . The indemnification and contribution provided for under
this Agreement will be in addition to any other rights to indemnification or contribution that any indemnified party may have pursuant to law or contract (and the Company and its subsidiaries shall be considered the indemnitors of first resort in
all such circumstances to which this Section 4 applies) and will remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director or controlling Person
of such indemnified party and will survive the transfer of Shares and the termination or expiration of this Agreement. 

  
 18 













 4.5 Rule 144. If the Company is subject to the requirements of Section 13, 14 or
15(d) of the Exchange Act, the Company covenants that it will file any reports required to be filed by it under the Securities Act and the Exchange Act (or, if the Company is subject to the requirements of Section 13, 14 or 15(d) of the
Exchange Act but is not required to file such reports, it will, upon the request of any Carlyle Stockholder, make publicly available such information) and it will take such further action as any Carlyle Stockholder may reasonably request, so as to
enable such Carlyle Stockholder to sell Shares without registration under the Securities Act within the limitation of the exemptions provided by (a) Rule 144 under the Securities Act, as such Rule may be amended from time to time, or
(b) any similar rule or regulation hereafter adopted by the SEC. Upon the request of any Carlyle Stockholder, the Company will deliver to such Carlyle Stockholder a written statement as to whether it has complied with such requirements. 

SECTION V. MISCELLANEOUS PROVISIONS 
 5.1
Information and Access Rights. 
 (a) Available Financial Information. Upon written request, the Company will deliver, or will
cause to be delivered, to each Carlyle Stockholder (until such time as such Carlyle Stockholder shall cease to own any Shares): 

(i) as soon as available after the end of each month and in any event within 30 days thereafter, a consolidated balance sheet
of the Company and its subsidiaries as of the end of such month and consolidated statements of operations, income, cash flows, retained earnings and shareholders’ equity of the Company and its subsidiaries, for each month and for the current
fiscal year of the Company to date, prepared in accordance with IFRS (subject to normal year-end audit adjustments and the absence of notes thereto), together with a comparison of such statements to the
corresponding periods of the prior fiscal year and to the Company’s business plan then in effect and approved by the Board of Directors; 

(ii) an annual budget, a business plan and financial forecasts for the Company for the fiscal year of the Company (the
“Annual Budget”), no later than three business days after the approval thereof by the Board of Directors (but no later than March 31 of such fiscal year), in such manner and form as approved by the Board of Directors, which
shall include at least a projection of income and a projected cash flow statement for each fiscal quarter in such fiscal year and a projected balance sheet as of the end of each fiscal quarter in such fiscal year, in each case prepared in reasonable
detail, with appropriate presentation and discussion of the principal assumptions upon which such budgets and projections are based, which shall be accompanied by the statement of the chief executive officer or chief financial officer or equivalent
officer of the Company to the effect that such budget and projections are based on reasonable and good faith estimates and assumptions made by the management of the Company for the respective periods covered thereby; it being recognized by such
holders that such budgets and projections as to future events are not to be viewed as facts and that actual results during the period or periods covered by them may differ from the projected results. Any material changes in such Annual Budget shall
be delivered to the Carlyle Stockholders as promptly as practicable after such changes have been approved by the Board of Directors; 

(iii) as soon as available after the end of each fiscal year of the Company, and in any event within 90 days thereafter,
(A) the annual financial statements required to be filed by the Company pursuant to the Exchange Act or (B) a consolidated balance sheet of the Company 

  
 19 













 
and its subsidiaries as of the end of such fiscal year, and consolidated statements of income, retained earnings and cash flows of the Company and its subsidiaries for such year, prepared in
accordance with IFRS and setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable detail and accompanied by the opinion of independent public accountants of recognized national standing selected by
the Company, and a Company-prepared comparison to the Company’s Annual Budget for such year as approved by the Board of Directors (the “Annual Financial Statements”); and 

(iv) as soon as available after the end of the first, second and third quarterly accounting periods in each fiscal year of the
Company, and in any event within 45 days thereafter, (A) the quarterly financial statements required to be filed by the Company pursuant to the Exchange Act or (B) a consolidated balance sheet of the Company and its subsidiaries as of the
end of each such quarterly period, and consolidated statements of income, retained earnings and cash flows of the Company and its subsidiaries for such period and for the current fiscal year to date, prepared in accordance with IFRS (subject to
normal year-end audit adjustments and the absence of notes thereto) and setting forth in comparative form the figures for the corresponding periods of the previous fiscal year and to the Company’s Annual
Budget then in effect as approved by the Board of Directors, all of the information to be provided pursuant to this Section 4.1(a)(iv) in reasonable detail and certified by the principal financial or accounting officer of the Company. 

In addition to the foregoing, the Company covenants and agrees to provide periodic updates to each Carlyle Stockholder during the course of
the preparation of the Annual Budget and to keep the Carlyle Stockholders reasonably informed as to its progress, status and the budgeted items set forth therein. Notwithstanding anything to the contrary in Section 5.1(a), the Company’s
obligations thereunder shall be deemed satisfied to the extent that such information is provided by (A) providing the financial statements of any wholly-owned subsidiary of the Company to the extent such financial statements reflect the
entirety of the operations of the business or (B) in the case of Section 5.1(a)(iii) and Section 5.1(a)(iv), filing such financial statements of the Company or any wholly-owned subsidiary of the Company whose financial statements
satisfy the requirements of clause (A), as applicable, with the Securities and Exchange Commission on EDGAR or in such other manner as makes them publicly available. The Company’s obligation to furnish the materials described in
Section 5.1(a)(i), Section 5.1(a)(iii) and Section 5.1(a)(iv), shall be satisfied so long as it transmits such materials to the requesting Carlyle Stockholders within the time periods specified therein, notwithstanding that such
materials may actually be received after the expiration of such periods. 
 (b) Tax Information. Promptly upon request by any Carlyle
Stockholder, the Company will, at the Company’s expense, prepare and deliver to such Carlyle Stockholder any information and certified statement that such Carlyle Stockholder determines to be necessary for such Carlyle Stockholder (or its
direct or indirect owners) to comply with obligations for tax reporting or tax withholding with respect to an investment (direct or indirect) in the Company or any of its subsidiaries. For the avoidance of doubt, such a request by any Carlyle
Stockholder may require the Company, (i) for purposes of Section 301 of the United States Internal Revenue Code of 1986, as amended (the “Code”), to prepare financial statements pursuant to the principles of “earnings
and profits” within the meaning of United States federal income tax law and to determine the amount of any “dividend” within the meaning of Section 316 of the Code, (ii) for purposes of Sections 951 and 951A of the Code, to
determine whether the Company or any of its subsidiaries is a “controlled foreign corporation” within the meaning of Section 957 of the Code, to prepare financial statements pursuant to the principles of “earnings and
profits” within the meaning of United States federal income tax law, and to determine the amount of any “subpart F income” within the meaning of Section 952 of the Code and any “global intangible low-taxed income” within the meaning of Section 951A of the Code, and (iii) for purposes of Section 1291 of the Code and the election under Section 1295 of the Code, to determine whether the
Company or any of its subsidiaries is a “passive foreign investment company” within the meaning of Section 1297 of the Code. 

  
 20 













 (c) Other Information. The Company covenants and agrees to deliver to each Carlyle
Stockholder, upon written request, until such time as such Carlyle Stockholder shall cease to own any Shares, with reasonable promptness, such other information and data (including such information and reports made available to any lender of the
Company or any of its subsidiaries under any credit agreement or otherwise) with respect to the Company and each of its subsidiaries as from time to time may be reasonably requested by any such Carlyle Stockholder. Each such Carlyle Stockholder,
until such time as such Carlyle Stockholder shall cease to own any Shares, shall have access to such other information concerning the Company’s business or financial condition and the Company’s management as may be reasonably requested,
including such information as may be necessary to comply with regulatory, tax or other governmental filings. 
 (d) Access. The
Company shall, and shall cause its subsidiaries, officers, directors, employees, auditors and other agents to (a) afford the Carlyle Stockholders and their officers, employees, auditors and other agents, during normal business hours and upon
reasonable notice, at all reasonable times to the Company’s and its subsidiaries’ officers, employees, auditors, legal counsel, properties, offices, plants and other facilities and to all books and records, and (b) afford the Carlyle
Stockholders and their officers, employees, auditors and other agents the opportunity to discuss the affairs, finances and accounts of the Company and its subsidiaries with their respective officers from time to time as each such Carlyle Stockholder
may reasonably request, in each case, until such time as such Carlyle Stockholder shall cease to own any Shares. 
 5.2
Confidentiality. Each Stockholder agrees that it will keep confidential and will not disclose, divulge or use for any purpose, other than to monitor its investment in the Company and its subsidiaries, any confidential information obtained
from the Company pursuant to Section 5.1, unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of any confidentiality obligation by such Stockholder or its
affiliates), (b) is or has been independently developed or conceived by such Stockholder without use of the Company’s confidential information, (c) is or has been made known or disclosed to such Stockholder by a third party (other than an
Affiliate of such Stockholder) without a breach of any confidentiality obligations such third party may have to the Company that is known to such Stockholder, or (d) that is communicated to it free of any obligation of confidentiality;
provided, that, a Stockholder may disclose confidential information (i) to its attorneys, accountants, consultants, investment advisors and other professional advisors to the extent necessary to obtain their services in connection
with monitoring its investment in the Company, (ii) to any prospective purchaser of any Shares from such Stockholder as long as such prospective purchaser agrees to be bound by the provisions of this Section 5.2 as if a Stockholder,
(iii) to any Affiliate, general partner, partner, member, limited partners, prospective partners or related investment fund of such Stockholder and their respective directors, officers, investment committees, agents, employees, consultants and
representatives, (including without limitation, attorneys, accountants, consultants and financial advisors and other professionals) (provided that the recipients of such confidential information are subject to a customary confidentiality and non-disclosure obligation), (iv) as may be reasonably determined by such Stockholder to be necessary in connection with such Stockholder’s enforcement of its rights in connection with this Agreement or its
investment in the Company and its subsidiaries, (v) as may otherwise be required by any applicable law or regulation, regulatory body, stock exchange, court or administrative order, or any listing or trading agreement applicable to such Carlyle
Stockholder, or (vi) as otherwise agreed by the Company. 
 5.3 Reliance. Each covenant and agreement made by a party in this
Agreement or in any certificate, instrument or other document delivered pursuant to this Agreement is material, shall be deemed to have been relied upon by the other parties and shall remain operative and in full force and effect after the Effective
Date regardless of any investigation. This Agreement shall not be construed so as to confer any right or benefit upon any Person other than the parties hereto and their respective successors and permitted assigns. 

  
 21 













 5.4 Access to Agreement; Amendment and Waiver; Actions of the Board. For so long as
this Agreement shall be in effect, this Agreement shall be made available for inspection by any Stockholder at the principal executive offices of the Company. Any party may waive in writing any provision hereof intended for its benefit, provided,
that, in the case of any waiver by the Company, such waiver is consented to in writing by the Carlyle Majority Interest. No failure or delay on the part of any party in exercising any right, power or remedy hereunder shall operate as a waiver
thereof. It is further agreed that any waiver, permit, consent or approval of any kind or character on any party’s part of any breach, default or noncompliance under this Agreement or any waiver on such party’s part of any provisions or
conditions of this Agreement must be in writing and shall be effective only to the extent specifically set forth in such writing. The remedies provided for herein are cumulative and are not exclusive of any remedies that may be available to any
party at law or in equity or otherwise. This Agreement may be amended only with the prior written consent of the Carlyle Majority Interest and the Company. Any consent given as provided in the preceding sentence shall be binding on all parties.
Further, with the prior written consent of the Carlyle Majority Interest and the Company, at any time hereafter Permitted Transferees may be made parties hereto, with any such additional parties shall be treated as “Stockholders” for all
purposes hereunder, by executing a counterpart signature page in the form attached as Exhibit A hereto, which signature page shall be attached to this Agreement and become a part hereof without any further action of any other party hereto. 

5.5 Notices. All notices, requests, demands and other communications provided for hereunder shall be in writing and mailed (by first
class registered or certified mail, postage prepaid), sent by express overnight courier service, or delivered to the applicable party at the respective address indicated below: 

If to the Company: 

Atotech Limited 
 William Street,
West Bromwich 
 West Midlands, B70 OB6 

United Kingdom 
 Attn: General
Counsel 
 With a copy (which shall not constitute notice): 

Latham & Watkins LLP 

555 Eleventh Street, N.W. 

Washington, D.C. 20004 

Attention: Patrick H. Shannon 

Facsimile: (202) 637-2201 

If to the Carlyle Stockholders: 

c/o The Carlyle Group 
 1001
Pennsylvania Avenue, N.W. 
 Washington, DC 20004 

Attention: Martin W. Sumner 

Facsimile: (202) 347-1818 

  
 22 













 With a copy (which shall not constitute notice): 

Latham & Watkins LLP 

555 Eleventh Street, N.W. 

Washington, D.C. 20004 

Attention: Patrick H. Shannon 

Facsimile: (202) 637-2201 

If to any other Stockholder: 

At such Person’s address for notice as set forth in the books and records of the Company, or, as to each of the foregoing, at such other
address as shall be designated by a party in a written notice to other parties complying as to delivery with the terms of this Section 5.5. All such notices, requests, demands and other communications shall, when mailed, telegraphed or sent,
respectively, be effective (i) two days after being deposited in the mail or (ii) one day after being deposited with the express overnight courier service, respectively, addressed as aforesaid. 

5.6 Counterparts. This Agreement may be executed in two or more counterparts, and delivered via facsimile, .pdf or other electronic
transmission, each of which shall be deemed an original, but all of which together shall constitute one and the same agreement. 
 5.7
Remedies; Severability. It is specifically understood and agreed that any breach of the provisions of this Agreement by any party will result in irreparable injury to the other parties, that the remedy at law alone will be an inadequate
remedy for such breach, and that, in addition to any other legal or equitable remedies which they may have, such other parties may enforce their respective rights by actions for specific performance or injunctive relief (to the extent permitted at
law or in equity). If any one or more of the provisions of this Agreement, or the application thereof in any circumstances, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any
such provision in every other respect and of the remaining provisions contained herein are not to be in any way impaired thereby, it being intended that all of the rights and privileges of the parties be enforceable to the fullest extent permitted
by law. 
 5.8 Entire Agreement. This Agreement constitutes the entire agreement of the Parties with respect to the subject matter
hereof. Each party expressly represents and warrants that it is not relying on any oral or written representations, warranties, covenants or agreements outside of this Agreement. 

5.9 Termination. This Agreement shall (A) with respect to sections II, III, IV (other than with respect to subsection 4.4) and V
(other than with respect to subsections 5.7, 5.8, 5.10, 5.11 and 5.12) terminate on the earlier of (i) the election of the Carlyle Majority Interest or (ii) such date as the Carlyle Stockholders, in the aggregate, cease to hold any Shares
and (B) with respect to all other sections, not terminate. 
 5.10 Governing Law. To the greatest extent permitted by Jersey
law, this Agreement is to be construed and enforced in accordance with the laws of the State of Delaware, without giving effect to its principles or rules of conflict of laws to the extent such principles or rules are not mandatorily applicable by
statute and would require or permit the application of the laws of another jurisdiction. 
 5.11 Successors and Assigns;
Beneficiaries. This Agreement shall be binding upon and inure to the benefit of the parties and the respective successors and assigns of the parties as contemplated herein. Any successor to the Company by way of merger or otherwise must
specifically agree to be bound by the terms hereof as a condition of such succession. 

  
 23 













 5.12 Consent to Jurisdiction; Specific Performance; Waiver of Jury Trial. 

(a) Each of the parties hereto irrevocably and unconditionally consents to the sole and exclusive jurisdiction of the state and federal courts
located in Wilmington, Delaware to resolve all disputes, claims or controversies arising out of or relating to this Agreement or any other agreement executed and delivered pursuant to or in connection with this Agreement or the negotiation, breach,
validity, termination or performance hereof and thereof or the transactions contemplated hereby and thereby and agrees that it will not bring any such action in any court other than the federal or state courts located in Wilmington, Delaware. Each
party further irrevocably waives any objection to proceeding in such courts based upon lack of personal jurisdiction or to the laying of venue in such courts and further irrevocably and unconditionally waives and agrees not to make a claim that such
courts are an inconvenient forum. Each of the parties hereto hereby consents to service of process by registered mail at the address to which notices are to be given as provided in Section 5.5. Each of the parties hereto agrees that its or his
submission to jurisdiction and its or his consent to service of process by mail is made for the express benefit of the other parties hereto. The choice of forum set forth in this Section shall not be deemed to preclude the enforcement of any
judgment of a Delaware federal or state court, or the taking of any action under this Agreement to enforce such a judgment, in any other appropriate jurisdiction. 

(b) The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in
accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions
of this Agreement, this being in addition to any other remedy to which such party is entitled at law or in equity. 
 (c) TO THE GREATEST
EXTENT PERMITTED BY JERSEY LAW, EACH PARTY TO THIS AGREEMENT WAIVES TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY ANY OF THEM AGAINST THE OTHER ARISING OUT OF OR IN ANY WAY CONNECTED WITH THIS AGREEMENT, OR ANY OTHER AGREEMENTS
EXECUTED AND DELIVERED PURSUANT TO OR IN CONNECTION HEREWITH OR THE NEGOTIATION, BREACH, VALIDITY, TERMINATION OR PERFORMANCE HEREOF AND THEREOF OR THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY. FURTHER, (I) NO PARTY TO THIS AGREEMENT SHALL
SEEK A JURY TRIAL IN ANY SUCH ACTION AND (II) NO PARTY WILL SEEK TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED. EACH PARTY TO THIS AGREEMENT
CERTIFIES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT OR INSTRUMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS SET FORTH ABOVE IN THIS SECTION 4.12. NO PARTY HAS IN ANY WAY AGREED WITH OR REPRESENTED TO ANY OTHER PARTY
THAT THE PROVISIONS OF THIS SECTION WILL NOT BE FULLY ENFORCED IN ALL INSTANCES. 
 5.13 Further Assurances; Company Logo. At any
time or from time to time after the Effective Date, the parties hereto agree to cooperate with each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as any
other party may reasonably request in order to evidence or effectuate the provisions of this Agreement and to otherwise carry out the intent of the parties hereunder. The Company hereby grants the Carlyle Stockholders and their respective Affiliates
permission to use the Company’s and its subsidiaries’ name and logo in marketing materials. 
 5.14 Regulatory Matters. The
Company shall and shall cause its subsidiaries to keep the Carlyle Stockholders informed, on a current basis, of any events, discussions, notices or changes with respect to any 

  
 24 













 
criminal or regulatory investigation or action involving the Company or any of its subsidiaries, so that the Carlyle Stockholders and their respective Affiliates will have the opportunity to take
appropriate steps to avoid or mitigate any regulatory consequences to them that might arise from such investigation or action. 
 5.15
Inconsistent Agreements. Neither the Company nor any Stockholder shall enter into any agreement or side letter with, or grant any proxy to, any Stockholder, the Company or any other Person (whether or not such proxy, agreements or side
letters are with other Stockholders, holders of Common Shares that are not parties to this Agreement or otherwise) that conflicts with the provisions of this Agreement or which would obligate such Person to breach any provision of this Agreement.

 5.16 In-Kind Distributions. If any of the Carlyle Stockholders (and/or any of their
affiliates) seeks to effectuate an in-kind distribution of all or part of its Shares to its respective direct or indirect equity holders, the Company will, subject to any applicable lock-ups, work with the foregoing Persons to facilitate such in-kind distribution in the manner reasonably requested and consistent with the Company’s obligations under
the Securities Act. 
 5.17 Recapitalization Transactions. If at any time or from time to time there is any change in the capital
structure of the Company by way of stock split, stock dividend, combination or reclassification, or through a merger, consolidation, reorganization or recapitalization, or by other means, appropriate adjustments will be made in the provision hereof
so that the rights and privileges granted hereby will continue. 
 5.18 Conflict with Jersey Law. In the event of a conflict between
the provisions of Jersey law and this Agreement (or any conflict with Delaware law), the parties shall cooperate to effectuate the provisions of this Agreement in accordance with, and take such actions as may be required to satisfy, the requirements
of Jersey law (or Delaware law, as applicable), including taking all Necessary Actions to fully effectuate the intents and purposes of this Agreement while satisfying any requirement of Jersey Law (or Delaware law, as applicable). Notwithstanding
any other provisions of this Agreement, to the extent not inconsistent with the Memorandum of Association, the Articles and Jersey Companies Law (or Delaware law), the Company undertakes to be bound by and comply with the terms and conditions of
this Agreement insofar as the same relates to the Company and any Subsidiaries of the Company and to act in all respects as contemplated by this Agreement. 

[Signature Pages Follow] 

  
 25 













 IN WITNESS WHEREOF, the parties are signing this Principal Stockholders Agreement as of the
date first set forth above. 
 COMPANY: 

 

			
	ATOTECH LIMITED
		
	By:	 	/s/ Geoff Wild
		 	Name: Geoff Wild
		 	Title: Chief Executive Officer



  
 [Signature page to
Principal Stockholders Agreement] 













 INITIAL CARLYLE STOCKHOLDERS: 

 

			
	CARLYLE PARTNERS VI CAYMAN HOLDINGS, L.P.
		
	By:	 	/s/ Jeremy Anderson
		 	Name: Jeremy Anderson
		 	Title: Authorized Signatory
	
	CEP IV PARTICIPATIONS, S.A.R.L. SICAR
		
	By:	 	/s/ Andrew Howlett-Bolton
		 	Name: Andrew Howlett-Bolton
		 	Title: Authorized Signatory
	
	GAMMA HOLDING COMPANY LIMITED
		
	By:	 	/s/ Ryan R. Toteja
		 	Name: Ryan R. Toteja
		 	Title: Authorized Signatory



  
 [Signature page to
Principal Stockholders Agreement] 













 EXHIBIT A 

Joinder Agreement 
 By execution of this
signature page, [_______________] hereby agrees to become a Party to, and to be bound by the obligations of, and receive the benefits of, that certain Principal Stockholders Agreement, dated as of February 3, 2021, by and among Atotech Limited,
a Jersey company, Carlyle Partners VI Cayman Holdings, L.P. (“CP-VI”), CEP IV Participations, S.à r.l. SICAR (“CEP IV”), Gamma Holding Company Limited (“Gamma
Holding” and, together with CP-VI, Atotech Beteiligungs, Ato Cayman and CEP IV, the “Initial Carlyle Stockholders”), and certain other Parties named therein, as amended from time to
time thereafter. 
 [_______________] hereby represents, warrants and covenants to the Company and the Carlyle Stockholders as follows: (a) such Person
has full legal capacity to enter into this Joinder Agreement and the Principal Stockholders Agreement and perform its obligations hereunder and thereunder; (b) this Agreement constitutes the valid and binding obligation of such Person
enforceable against such Person in accordance with its terms; and (c) the execution, delivery and performance by such Person of this Agreement does not and will not: (i) violate any laws, rules or regulations of the United States or any
state or other jurisdiction applicable to such Person, or require such Person to obtain any approval, consent or waiver of, or to make any filing with, any Person that has not been obtained or made; or (ii) constitute a breach of or default
under any material agreement to which such Person is a party. 
  

			
	[NAME]
		
	By:	 	 
	Name:	 	
	Title:	 	
	
	 Notice Address:

	 
	 


  

			
	Accepted:
	
	 ATOTECH LIMITED

		
	By:	 	 
	Name:	 	
	Title: